REELD will exhibit at ASHG 2026 — October 20–24, Montréal.Meet our team at the meeting
Abstract map of cellular structures and a rare genomic signal
Rare disease computational biology

Rare variants.Clearer disease biology.

We connect genomic variation to cell states, phenotypes, and testable therapeutic hypotheses.

One disease mechanism, tested from four directions.

We build evidence that can survive a new dataset, a changed parameter, and a skeptical reader.

From association to an experiment worth running.

Every REELD hypothesis carries its evidence path, competing explanations, and conditions for failure.

See our methods
ReproducibilityIndependent references and sensitivity tests.
ProvenanceVersioned inputs and auditable transformations.
FalsifiabilityPredictions paired with ways they can fail.

Case studies

See how the framework behaves when the evidence is incomplete, heterogeneous, and sensitive to context.

All case studies

Critical review is part of the research.

Our editorials examine the assumptions that decide whether a computational result can travel.

All editorials

Built on our own research, engaged with leading campuses.

Our analyses draw on our own research and findings, alongside engagement with investigators and scholarship at leading research campuses.

How we collaborate
Stanford University
MIT
The University of Texas
Broad Institute
Harvard Medical School
UC San Diego